PRESS RELEASE
from CompuGroup Medical SE & Co. KGaA (isin : DE000A288904)
EQS-Adhoc: CompuGroup Medical SE & Co. KGaA confirms discussions for potential significant investment of CVC
EQS-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Tender Offer
CompuGroup Medical SE & Co. KGaA confirms discussions for potential significant investment of CVC
08-Dec-2024 / 23:01 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
CompuGroup Medical SE & Co. KGaA (Company) confirms that the Company and the shareholder group around the founding family Gotthardt are in advanced discussions with the private equity firm CVC Capital Partners plc (CVC) regarding a potential conclusion of an investment agreement for the submission of a voluntary public tender offer to the shareholders of the Company. The discussions also include a later delisting of shares of the Company from the regulated market. Starting point is a potential offer price of EUR 22.00 per share that CVC has indicated to the Company in the event of a public tender offer, which is subject, in particular, to final board decisions and the signing of transaction documents.
In the event of the potential transaction being implemented, the shareholder group around the Gotthardt family intends to remain invested in the Company to the same extent as before, with around 50,1% and, subject to the outcome of the ongoing discussions, to establish a strategic partnership with CVC.
The Company will inform the public and the capital market about further relevant developments in accordance with the legal requirements.
In the event of the potential transaction being implemented, the shareholder group around the Gotthardt family intends to remain invested in the Company to the same extent as before, with around 50,1% and, subject to the outcome of the ongoing discussions, to establish a strategic partnership with CVC.
The Company will inform the public and the capital market about further relevant developments in accordance with the legal requirements.
End of Inside Information
08-Dec-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
Language: | English |
Company: | CompuGroup Medical SE & Co. KGaA |
Maria Trost 21 | |
56070 Koblenz | |
Germany | |
Phone: | +49 (0)160 3630362 |
Fax: | +49 (0)261 8000 3200 |
E-mail: | investor@cgm.com |
Internet: | www.cgm.com |
ISIN: | DE000A288904 |
WKN: | A28890 |
Indices: | SDAX, TecDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 2046393 |
End of Announcement | EQS News Service |
2046393 08-Dec-2024 CET/CEST